면역치료제 시장 : 치료 유형별, 투여 경로별, 적응증별, 유통 채널별, 지역별
Immunotherapy Drugs Market, By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By Geography
상품코드
:
1672713
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 면역치료제 시장 규모는 2025년에 1,857억 2,000만 달러를 기록할 것으로 추정됩니다. 2032년에는 3,981억 6,000만 달러에 이를 것으로 예측되며, 2025-2032년에 걸쳐 CAGR 11.5%로 성장할 것으로 전망됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
1,857억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
11.50% |
2032년 금액 예측 |
3,981억 6,000만 달러 |
그림. 면역치료제 시장 점유율(%), 2025년, 지역별
면역치료제는 암이나 다른 질병과 싸우기 위해 신체의 면역 체계를 이용합니다. 이러한 약물은 기존 면역 세포를 활성화하거나 신체에 새로운 면역 세포를 도입하여 면역계를 자극합니다. 면역요법의 주요 유형으로는 단일 클론 항체, 암 백신, 체크포인트 억제제, 입양세포 이식요법 등이 있습니다. 면역치료제는 화학요법에 비해 부작용이 가볍고 주효율이 장기간 지속되는 것으로 나타났기 때문에 다양한 암종에 대한 표준치료가 되고 있습니다. 이 시장은 신약의 승인과 다양한 질병에 대한 적응 확대로 지난 몇 년 동안 크게 성장하고 있습니다.
시장 역학
세계의 면역치료제 시장 성장은 세계 암 및 기타 만성 질환의 유병률 증가로 이어지고 있습니다. 신규 면역요법 개발을 위한 연구개발 자금 증가, FDA에 의한 면역요법의 일관된 승인, 다른 치료법에 대한 우위성 등의 요인에 의해 시장은 기세를 늘리고 있습니다. 그러나 이러한 약물과 관련된 고가의 비용과 일부 지역의 상환 문제는이 시장의 주요 억제요인이 되었습니다. 시장 관계자는 또한 현재의 치료 상황을 새로운 적응증으로 확대하기 위해 파이프라인 제품에 투자하고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 면역치료제 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등과 같은 매개변수를 기반으로 세계의 면역치료제 시장 주요 기업을 프로파일링합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계의 면역치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 산업의 다양한 이해관계자를 지원합니다.
- 이해관계자들은 세계의 면역치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 인수와 제휴 시나리오
- 기술 개요
- 규제 시나리오
- 가격 분석
- PEST 분석
제4장 세계의 면역치료제 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부의 대처
- COVID-19에 의한 시장 영향
제5장 세계의 면역치료제 시장, 치료 유형별(2020-2032년), 10억 달러
- 서론
- 면역 관문 억제제
- 단일 클론 항체
- 네이키드 단일 클론 항체
- 접합 단일 클론 항체
- 이중 특이적 단일 클론 항체
- 백신
- 예방 백신
- 치료 백신
- 입양 세포 치료
- 종양 침윤 림프구(TIL) 치료
- CAR T 세포 치료
- 변형 T 세포 수용체(TCR) 치료
- 자연 살해(NK) 세포 치료
- 면역계 조절제
- 인터페론
- 면역 조절제(IMiD)
- 인터루킨
- 종양 용해성 바이러스 치료
제6장 세계의 면역치료제 시장, 투여 경로별(2020-2032년), 10억 달러
- 서론
- 정맥 내(IV)
- 경구용
- 근육 내
- 피하
- 기타
제7장 세계의 면역치료제 시장, 적응증별(2020-2032년), 10억 달러
- 서론
- 암
- 폐암
- 림프종
- 유방암
- 피부암
- 방광암
- 대장암
- 신장암
- 기타
- 자가면역질환
- 기타
제8장 세계의 면역치료제 시장, 유통 채널별(2020-2032년), 10억 달러
제9장 세계의 면역치료제 시장, 지역별(2020-2032년), 10억 달러
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
아프리카
제10장 경쟁 구도
- 기업 프로파일
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck &Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis
제11장 애널리스트 추천
제12장 참고문헌과 조사방법
KTH
영문 목차
Global Immunotherapy Drugs Market is estimated to be valued at USD 185.72 Bn in 2025 and is expected to reach USD 398.16 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 185.72 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
11.50% |
2032 Value Projection: |
USD 398.16 Bn |
Figure. Immunotherapy Drugs Market Share (%), By Region 2025
Immunotherapy drugs utilize the body's immune system to fight cancer and other diseases. These drugs stimulate the immune system by either boosting existing immune cells or introducing new immune cells into the body. The major types of immunotherapies include monoclonal antibodies, cancer vaccines, checkpoint inhibitors, and adoptive cell transfer therapies. Immunotherapy drugs are increasingly becoming the standard of care for various cancer types as these have been shown to provide long-lasting response rates with milder side effects compared to chemotherapy. The market has witnessed significant growth over the past few years driven by new drug approvals and increasing adoption across different disease indications.
Market Dynamics:
Global immunotherapy drugs market growth is driven by rising prevalence of cancer and other chronic diseases worldwide. The market has gained momentum due to factors such as an increase in R&D funding for developing novel immunotherapies, consistent FDA approvals of immunotherapies, and superiority over other available treatment options. However, high costs associated with these drugs along with reimbursement issues in some regions act as key restraints for this market. The market players are also investing in pipeline products for expanding the current treatment landscape to new indications.
Key Features of the Study:
- This report provides in-depth analysis of the global immunotherapy drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global immunotherapy drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Bristol-Myers Squibb Company, Pfizer Inc, Novartis AG, Merck & Co., Inc., AstraZeneca, Amgen Inc., GSK plc., Gilead Sciences, Inc., Johnson & Johnson, Actym Therapeutics, Inc., Fate Therapeutics., Gritstone bio, Incyte, Acumen Pharmaceuticals, Inc, Arcus Biosciences, Inc., immunitybio inc, Autolus Therapeutics, ADC Therapeutics SA., BioNTech SE, and Cellectis.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global immunotherapy drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunotherapy drugs market.
Detailed Segmentation-
- Therapy Type:
- Immune checkpoint inhibitors
- Monoclonal antibodies
- Naked monoclonal antibodies
- Conjugated monoclonal antibodies
- Bispecific monoclonal antibodies
- Vaccines
- Preventive Vaccines
- Therapeutic Vaccines
- Adoptive Cell Therapies
- Tumor-infiltrating lymphocyte (TIL) therapy
- CAR T-cell therapy
- Engineered T-cell receptor (TCR) therapy
- Natural killer (NK) cell therapy
- Immune System Modulators
- Interferons
- Immunomodulators (IMiDs)
- Interleukins
- Oncolytic Virus Therapy
- Route of Administration:
- Intravenous (IV)
- Oral
- Intramuscular
- Subcutaneous
- Others
- Indication:
- Cancer
- Lung Cancer
- Lymphoma
- Breast Cancer
- Skin Cancer
- Bladder Cancer
- Colorectal Cancer
- Kidney Cancer
- Others
- Autoimmune Diseases
- Others
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics.
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Immunotherapy Drugs Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Immunotherapy Drugs Market, By Therapy Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Immune checkpoint inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Monoclonal antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Naked monoclonal antibodies
- Conjugated monoclonal antibodies
- Bispecific monoclonal antibodies
- Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Preventive Vaccines
- Therapeutic Vaccines
- Adoptive Cell Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tumor-infiltrating lymphocyte (TIL) therapy
- CAR T-cell therapy
- Engineered T-cell receptor (TCR) therapy
- Natural killer (NK) cell therapy
- Immune System Modulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Interferons
- Immunomodulators (IMiDs)
- Interleukins
- Oncolytic Virus Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Immunotherapy Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Intravenous (IV)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Immunotherapy Drugs Market, By Indication, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lung Cancer
- Lymphoma
- Breast Cancer
- Skin Cancer
- Bladder Cancer
- Colorectal Cancer
- Kidney Cancer
- Others
- Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Immunotherapy Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Immunotherapy Drugs Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
